Bio Protocol vs Polyhedra Network — how do they compare? Bio Protocol trades at Rp495.27 (market cap Rp1,12T, Rp283,83M 24h volume), while Polyhedra Network trades at Rp123.33 (market cap Rp95,85M, Rp46,77M 24h volume). The key difference: Bio Protocol is far larger — about 11684.9× Polyhedra Network's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 775,6M / 1B ZKJ (78%) for Polyhedra Network. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Polyhedra Network for 19 Days on average.
| BIO | ZKJ | |
|---|---|---|
Market Cap | Rp1,12T | Rp95,85M |
Volume (24h) | Rp283,83M | Rp46,77M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 775,6M / 1B ZKJ (78%) |
Typical Hold Time | 16 Days | 19 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Polyhedra Network (ZKJ) is trading at Rp124.37 with a market cap of Rp96.38 million, showing a bearish technical signal overall. The asset is near support at S1 (Rp124) and below the pivot point (Rp126), with moving averages indicating a strong sell bias. RSI_6 at 28.56 suggests potential oversold conditions, while ADX readings show a strengthening trend. No recent protocol updates or major ecosystem developments were identified.
The outlook remains cautious due to bearish momentum and limited fundamental catalysts. Key opportunities include oversold bounce potential from support levels, but risks include low liquidity, high volatility, and absence of recent positive developments. Investors should monitor for any network updates or exchange listing news that could shift sentiment.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Polyhedra Network is revolutionizing the digital landscape by enhancing computational power and enabling seamless interoperability across blockchain, Web2, and Web3. Its flagship technology, zkBridge, facilitates trustless and efficient transactions while also serving as a platform for developing and testing its proof system. By evolving into a general zero-knowledge (ZK) interoperability protocol, Polyhedra connects Web2 and Web3 applications and allows real-world assets to be brought on-chain. With advanced algorithms and innovative protocols, Polyhedra provides developers with a robust foundation to create a wide range of applications, driving a more connected, efficient, and secure digital future.
Read more on ZKJ →